Justin Schreiber | executive |
Marc Benathen | executive |
David Larsen | analyst |
Sarah James | analyst |
Yi Chen | analyst |
Brandon Carney | analyst |
Good afternoon. Thank you for joining us today to discuss the results for LifeMD's Third Quarter Ended September 30, 2023.
Joining the call today are Justin Schreiber, Chairman and Chief Executive Officer; and Marc Benathen, Chief Financial Officer of LifeMD.
Following management's prepared remarks, we will open the call for a question-and-answer session.Before we begin, I'd like to remind everyone that during this call, the company will make a number of forward-looking statements which are subject to numerous risks and uncertainties that may cause actual results to differ materially from those projected. These risks and uncertainties are described in the company's 10-K and 10-Q filings and within other filings that LifeMD may have with the SEC from time to time.